Petros Gatsios/LinkedIn
Nov 5, 2025, 06:51
Petros Gatsios Explains Why Europe Must Become Self-Sufficient in Maintaining Its Plasma Supply
PPTA Europe shared on LinkedIn:
”Plasma-derived medicinal products (PDMPs) are vital for patients with rare and serious conditions and can’t be made in a lab.
Yet the supply of these medicines is more important than ever.
In a guest article published in Tagesspiegel Background Gesundheit and E-Health, Petros Gatsios, Chairman of the Plasma Protein Therapeutics Association Germany, explains why Europe must become self-sufficient in maintaining its plasma supply and suggests patient-centric policies to better secure future supplies.
Read more about how Germany can lead the way toward a resilient, self-sufficient model in Europe.”
Stay updated with Hemostasis Today.
-
Apr 6, 2026, 16:39Dhinesh Selvaraju: FDA Approves Narsoplimab (Yartemlea) as 1st Treatment for TA-TMA in Adults and Children
-
Apr 6, 2026, 16:38Linda Vorberg: A Detailed Analysis on The Usefulness of CT for DL-Based Stroke Lesion Segmentation
-
Apr 6, 2026, 16:37Colleen Hearn: Telestroke Helps Resource-Limited Facilities Gain Access to Unavailable Expertise
-
Apr 6, 2026, 16:37Nicolas Hubacz: AI Maps Neuroplasticity in Stroke Recovery – How the Brain Adapts After Injury
-
Apr 6, 2026, 16:36Cristina de Diego Alonso: Movement Is Not Just an Exercise, It Is The Rhythm of Daily Life
-
Apr 6, 2026, 16:35Charles Okyere Boadu: What Is The Most Likely Cause of Persistent Thrombocytopenia Despite Transfusion?
-
Apr 6, 2026, 16:34Tumor Mutations and VTE Risk – New Insights from a 12,500-Patient Cancer Study – JTH
-
Apr 6, 2026, 16:31Wolfgang Miesbach: New Real-World Data Reveal Ongoing Burden in Moderate-to-Severe Haemophilia A
-
Apr 6, 2026, 16:26Heghine Khachatryan։ Targeting High Risk Antiphospholipid Syndrome in Pregnancy with Hydroxychloroquine